Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sarepta Therapeutics Stock (NASDAQ: SRPT) stock price, news, charts, stock research, profile.
Open | $127.21 |
Close | - |
Volume / Avg. | 215.50K / 1.41M |
Day Range | $125.80 - $127.29 |
52 Wk Range | 55.25 - 173.25 |
Market Cap | $12.16B |
P/E Ratio | 169.56 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 7.16% |
Days to Cover | 9.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sarepta Therapeutics (NASDAQ:SRPT) through any online brokerage.
Other companies in Sarepta Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Sarepta Therapeutics has a consensus price target of $185.86.
The stock price for Sarepta Therapeutics (NASDAQ: SRPT) is $125.99 last updated September 23, 2024 at 12:05 PM EDT.
There are no upcoming dividends for Sarepta Therapeutics.
Sarepta Therapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Sarepta Therapeutics.
Sarepta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.